| Product Catalog： | B026088 |
| CAS No.： |
|
| Product Name： | Baricitinib Impurity 88 |
| Purity： | >95% HPLC |
| Synonyms: | 2-(3-(4-(5,6-dioxo-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile |
| Molecular Formula: | C16H15N7O4S |
| Mol. Weight： | 401.4 |
| Appearance: | Yellow soild |
| Storage： | 2-8°C Refrigerator |
| Contact: | WhatsAPP: +86 17320513646
E-mail: anna@molcoo.com |
| Note: | We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only! |
| Background: | Baricitinib is a Janus kinase (JAK) inhibitor used in the treatment of various inflammatory and autoimmune diseases, such as rheumatoid arthritis. The specific impurity you mentioned, 2 - (3 - (4 - (5,6 - dioxo - 6,7 - dihydro - 5H - pyrrolo[2,3 - d]pyrimidin - 4 - yl) - 1H - pyrazol - 1 - yl) - 1 - (ethylsulfonyl)azetidin - 3 - yl)acetonitrile, may be formed during the synthesis process of baricitinib. Impurities in drugs can potentially affect the safety, efficacy, and quality of the drug product. Understanding and controlling these impurities is crucial for ensuring the quality and safety of baricitinib - based medications. |
China
